HealthCare Royalty Partners’ Revenue Financing Agreement with Spero Therapeutics

Laura Testa
Tagged:

Cadwalader advised HealthCare Royalty Partners on the deal.HealthCare Royalty Partners closed a revenue financing agreement for up to $125 million for Spero Therapeutics, Inc. (NASDAQ: SPRO), a…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here